Target intelligence / Profile preview

Fas apoptotic inhibitory molecule 2 (FAIM2)

Target
FAIM2
Molecular classification
Anti-apoptotic protein, Transmembrane BAX inhibitor motif-containing (TMBIM) protein family, Fas inhibitory molecule family, Neuronal membrane protein
01

Overview

Fas apoptotic inhibitory molecule 2 (FAIM2) is a neuronally expressed transmembrane protein belonging to the TMBIM (Transmembrane BAX Inhibitor Motif-containing) family, also known as lifeguard proteins. FAIM2’s primary function is to protect neuronal cells from Fas (CD95) receptor-mediated apoptosis by directly interfering with downstream signaling, particularly caspase-8 activation, thereby preventing cell death following various stress conditions. The protein also interacts with other apoptosis-related factors, including p53 and HSP90, and may regulate calcium channel activity and autophagy. FAIM2 is constitutively expressed in the nervous system, with upregulation or downregulation affecting vulnerability to neurodegenerative conditions, retinal degeneration, and some metabolic disorders. It is a potential therapeutic target for neuroprotective strategies, though its dual regulatory roles in both cell death and regeneration highlight the need for precise modulation to avoid interfering with adaptive neurogenesis and repair mechanisms.

Other names
Protein lifeguard 2LFG2KIAA0950LFGNMP35LIFEGUARDTMBIM2Neural membrane protein 35Transmembrane BAX inhibitor motif-containing protein 2NGP35
02

Mechanism of action

Drugs targeting FAIM2 would likely function through inhibition of the Fas/CD95-mediated extrinsic apoptotic pathway, interfering with caspase-8 activation downstream of Fas receptor signaling, modulation of intracellular calcium homeostasis, or regulation of autophagy/lysosomal function via LC3 interaction.

03

Biological functions

Negative regulation of apoptosis (cell death)Neuroprotection, especially preventing Fas-mediated apoptosis in neuronal cellsRegulation of neuron development (including cerebellar structure)Calcium channel activity and calcium homeostasisAutophagy (modulates autophagosome maturation via LC3 interaction)Negative regulation of extrinsic apoptotic signaling via death domain receptors
04

Disease associations

Neurological diseases (e.g., cerebral ischemia, Parkinson disease, meningitis)Retinal degeneration and photoreceptor apoptosisObesity (susceptibility linked to FAIM2 SNPs)Myocardial infarction risk (certain subpopulations, e.g., type 2 diabetes)Obsessive-compulsive disorder (gene association)
05

Safety considerations

Dual role in both apoptosis inhibition and neuronal regeneration complicates therapeutic targeting; inappropriate timing or dosing could suppress regenerative Fas/CD95 signals or excessively inhibit apoptosis.Potential impact on non-neuronal tissues unknown.Off-target modulation could affect immune or metabolic processes (e.g., obesity, myocardial infarction in specific populations via SNPs).
06

Biomarkers

Currently, no consensus biomarkers for patient selection or efficacy monitoring are described for FAIM2 in clinical settings.Its expression may serve as an indicator of susceptibility to certain neurologic and metabolic diseases (e.g., via SNP studies), but its utility as a clinical biomarker is not established.

Beyond the preview

Go deeper on Fas apoptotic inhibitory molecule 2 (FAIM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fas apoptotic inhibitory molecule 2 (FAIM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call